IL37 and psoriasis: Finally, we conducted a replication analysis for SNPs in the TLR2, TLR5, and ANKRD55 genes, which were previously associated with treatment response to IL-23 inhibitors in a pre-selected SNP association study of a cohort of 18 patients with moderate-to-severe psoriasis from Spain [18].